Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Joelle Makon

Physical Medicine & Rehabilitation Mechanicsville, VA Medical Doctor

NPI 1598021743 CMS profile 1387252

8254 Atlee Rd, Mechanicsville, VA 23116

Open in the dashboard

General payments

$1,842

122 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Joelle Makon of Mechanicsville, VA is reported in the CMS Open Payments database as having received $1,842 across 122 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $90 1
2023 General $18 1
2022 General $31 2
2021 General $326 19
2020 General $461 28
2019 General $916 71

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joelle Makon
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Joelle Makon were reported at $0. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Joelle Makon Physical Medicine & Rehabilitation median Middle half National median
2019 $916 $133 $45–$390 $163
2020 $461 $88 $29–$272 $114
2021 $326 $116 $33–$360 $132
2022 $31 $123 $40–$378 $149
2023 $18 $131 $43–$396 $160
2024 $90 $141 $45–$409 $164
2025 $0 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Amgen Inc. $312 14 payments
  2. Teva Pharmaceuticals USA, Inc. $226 14 payments
  3. Arbor Pharmaceuticals, Inc. $224 38 payments
  4. Ipsen Biopharmaceuticals, Inc $206 7 payments
  5. Merz North America, Inc. $164 5 payments
  6. Novartis Pharmaceuticals Corporation $114 6 payments
  7. Scilex Pharmaceuticals Inc. $92 5 payments
  8. Allergan Inc. $90 6 payments
  9. Pfizer Inc. $61 4 payments
  10. US WorldMeds, LLC $58 4 payments
  11. Other $295 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $1,842 122 payments
Products named General payments · program years 2019–2024
  1. AIMOVIG $335 14 payments
  2. DYSPORT $206 7 payments
  3. Xeomin $179 6 payments
  4. AJOVY Central Nervous System $167 10 payments
  5. Horizant $143 33 payments
  6. EVENITY $91 6 payments
  7. Prolia $91 6 payments
  8. BOTOX $78 5 payments
  9. ZTLido $76 4 payments
  10. Ajovy Central Nervous System $59 4 payments
  11. Other $693 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

226

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$2,604

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

0%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dutasteride Generic 13 $661
Metolazone Generic 13 $319
Donepezil Hcl Generic 14 $316
Simvastatin Generic 16 $283
Gabapentin Generic 26 $232
Cephalexin Generic 14 $227
Potassium Chloride Generic 11 $127
Tamsulosin Hcl Generic 12 $95
Oxycodone Hcl Generic 28 $94
Pantoprazole Sodium Generic 13 $86

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 9 billing codes

Paid by Medicare

$162,656

Medicare's payments for the services billed

Medicare patients

387

Average age 79

Services billed

2,322

211 women, 176 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Ischemic heart disease 50%
Chronic kidney disease 49%
Depression 49%
Diabetes 46%
Atrial fibrillation 45%
Heart failure 43%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DYSPORT
  • Ipsen Biopharmaceuticals, Inc $90
$90 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

122 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record